SCHEMBL14848293

SCHEMBL14848293

COc1ccc2c(OCc3nnc4ccc(-c5c[nH]nn5)cn34)ccnc2c1

nearest known ligand 0.76

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MET P08581 20/20 0.76
CYP3A4 P08684 1/20 0.58
PRKACG P22612 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9910321 0.86 MET (1.00) METCYP3A4PRKACG
SCHEMBL2696028 0.85 MET (1.00) METCYP3A4PRKACG
SCHEMBL9910298 0.85 MET (0.79) MET
SCHEMBL9910323 0.85 MET (1.00) METCYP3A4PRKACG
SCHEMBL9910296 0.85 MET (0.82) METCYP3A4PRKACG
SCHEMBL9910322 0.85 MET (1.00) METCYP3A4PRKACG
SCHEMBL9910309 0.85 MET (0.75) MET
SCHEMBL9910316 0.84 MET (0.84) METCYP3A4PRKACG
SCHEMBL9910284 0.84 MET (0.84) METCYP3A4
SCHEMBL9910317 0.84 MET (0.79) METCYP3A4PRKACG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2578583-A1 Fused heterocyclic derivatives and methods of use Amgen Inc. (US) 2013-04-10 EP disclosed